Evolus (EOLS) EBITDA Margin: 2019-2025
Historic EBITDA Margin for Evolus (EOLS) over the last 7 years, with Sep 2025 value amounting to -22.15%.
- Evolus' EBITDA Margin rose 938.00% to -22.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -20.30%, marking a year-over-year increase of 207.00%. This contributed to the annual value of -19.11% for FY2024, which is 1145.00% up from last year.
- According to the latest figures from Q3 2025, Evolus' EBITDA Margin is -22.15%, which was up 9.08% from -24.36% recorded in Q2 2025.
- Evolus' EBITDA Margin's 5-year high stood at 52.29% during Q1 2021, with a 5-year trough of -72.85% in Q3 2021.
- For the 3-year period, Evolus' EBITDA Margin averaged around -25.40%, with its median value being -24.36% (2025).
- As far as peak fluctuations go, Evolus' EBITDA Margin spiked by 48,552bps in 2021, and later tumbled by 10,421bps in 2022.
- Over the past 5 years, Evolus' EBITDA Margin (Quarterly) stood at -52.45% in 2021, then surged by 2,236bps to -30.09% in 2022, then soared by 1,099bps to -19.10% in 2023, then spiked by 1,023bps to -8.88% in 2024, then soared by 938bps to -22.15% in 2025.
- Its last three reported values are -22.15% in Q3 2025, -24.36% for Q2 2025, and -27.47% during Q1 2025.